Susan Kelly
Chief Executive Officer at Respiratory Analytics The aflo platform uses sensor tech and data analytics to automate correct inhaler technique for better self management and remote monitoring in airways conditions
aflo™ uses AI, sensor tech and big data to help control life-threatening symptoms for people with asthma, COPD and cystic fibrosis. Supported by funding from Innovate UK, Techstart NI and CoFund we are designing and building the next generation 'smart inhaler'. aflo™ will teach you how to inhale your medicines correctly and aggregate your data with air quality and viral data to help you to identify symptom worsening and warn of possible exacerbation risk.
